Strategikon Pharma

Clinical Study Planning - Clinical Trial Business Operations | Clinical Maestro®

San Francisco, United States · Founded 2017 · $7.0M raised

Employees
11–50
Founded
2017
Business Model
SaaS
Total Funding
$7.0M
Last Round
$7.0M Series AFeb 2024
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Develops Clinical Maestro, AI-powered software suite that reduces clinical trial costs by 80% or more.

Summary

Strategikon Pharma is a Biotech company based in San Francisco, United States, founded in 2017. It has raised $7.0M in total across 2 rounds, most recently a $7.0M Series A round in Feb 2024. Investors include Osage Venture Partners, Debiopharm Innovation and Hearstlab.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AFeb 2024
$7.0M

Sign up to see all 2 events

Funding: Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Strategikon Pharma on Indexed.vc
<a href="https://indexed.vc/companies/strategikon-pharma"><img src="https://indexed.vc/api/badge/company/strategikon-pharma" alt="Strategikon Pharma on Indexed.vc" width="260" height="76" /></a>